Serum endocan levels in endometrial and ovarian cancers

Creative Commons License

LALOĞLU E., KUMTEPE Y., Aksoy H., Yilmaz E. P.

JOURNAL OF CLINICAL LABORATORY ANALYSIS, cilt.31, sa.5, 2017 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 31 Sayı: 5
  • Basım Tarihi: 2017
  • Doi Numarası: 10.1002/jcla.22079
  • Dergi Adı: JOURNAL OF CLINICAL LABORATORY ANALYSIS
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Anahtar Kelimeler: cancer antigen 125, endocan, endometrial cancer, ESM-1, ovarian cancer, ENDOTHELIAL GROWTH-FACTOR, VEGF-A, VASCULAR ENDOCAN, CA 125, EXPRESSION, HE-4, CARCINOMA, DIAGNOSIS, BIOMARKER, SURVIVAL
  • Atatürk Üniversitesi Adresli: Evet

Özet

BackgroundOvarian and endometrial carcinomas are the two most common malignancies of the female reproductive system. Endocan is a proteoglycan that is specific to vascular endothelial cells. Increased serum levels have been reported in some tumors. The aim of this study was to investigate serum endocan levels in cases of endometrial and ovarian cancer.